Tatsunori Shimizu
Overview
Explore the profile of Tatsunori Shimizu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
23
Citations
274
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Sato T, Shimizu T, Fujita H, Imai Y, Drucker D, Seino Y, et al.
Endocrinology
. 2020 Oct;
161(12).
PMID: 33125041
A number of disease states, including type 2 diabetes (T2D), are associated with an increased risk of pulmonary infection. Glucagon-like peptide-1 (GLP-1) receptor agonists are used to treat T2D and...
12.
Otomo H, Nara M, Kato S, Shimizu T, Suganuma Y, Sato T, et al.
Metabolism
. 2020 Oct;
113:154405.
PMID: 33069809
Aims: The crosstalk between sodium-glucose cotransporter 2 (SGLT2) inhibition and a membrane-associated endocytic receptor megalin function involved in renal proximal tubular protein overload in progressive diabetic nephropathy (DN) is uncertain....
13.
Suganuma Y, Shimizu T, Sato T, Morii T, Fujita H, Sassa M, et al.
J Diabetes Investig
. 2019 Jul;
11(2):389-399.
PMID: 31301103
Aims/introduction: Pharmacological levels of glucagon-like peptide-1 (GLP-1) can decelerate gastric emptying (GE) and reduce postprandial glucose levels. Most previous studies have used liquid meals to evaluate GE. We evaluated the...
14.
Hoizumi M, Sato T, Shimizu T, Kato S, Tsukiyama K, Narita T, et al.
Biochem Biophys Res Commun
. 2019 Apr;
513(4):974-982.
PMID: 31003779
Aims/introduction: Caloric restriction (CR) promotes longevity and exerts anti-aging effects by increasing Sirtuin production and activation. Gastric inhibitory polypeptide (GIP), a gastrointestinal peptide hormone, exerts various effects on pancreatic β-cells...
15.
Takashima S, Narita T, Otomo H, Shimizu T, Yamada Y
Diabetol Int
. 2019 Jan;
9(3):196-200.
PMID: 30603367
We herein report a case of a 60-year-old female receiving hemodialysis who developed severe hyperinsulinemic hypoglycemia and lost her consciousness. A calcimimetic agent had been administered for the secondary hyperparathyroidism....
16.
Shimizu T, Sato T, Tsukiyama K, Fujita H, Kato S, Hoizumi M, et al.
Endocrinology
. 2017 Apr;
158(7):2134-2144.
PMID: 28430907
In addition to overeating, starvation also reduces fecundity in mammals. However, little is known about the molecular mechanisms linking food intake to fertility, especially in males. Gastric inhibitory polypeptide (GIP),...
17.
Takashima S, Fujita H, Fujishima H, Shimizu T, Sato T, Morii T, et al.
Kidney Int
. 2016 Aug;
90(4):783-96.
PMID: 27475229
The role of stromal cell-derived factor-1 (SDF-1) in the pathogenesis of diabetic nephropathy and its modification by dipeptidyl peptidase-4 (DPP-4) inhibition are uncertain. Therefore, we studied this independent of glucagon-like...
18.
Shimizu T, Narita T
Nihon Rinsho
. 2016 Jun;
74 Suppl 2:556-60.
PMID: 27266152
No abstract available.
19.
Yamada Y, Tsukiyama K, Sato T, Shimizu T, Fujita H, Narita T
J Diabetes Investig
. 2016 May;
7 Suppl 1:76-9.
PMID: 27186360
The hormonal factors implicated as transmitters of signals from the gut to pancreatic β-cells are referred to as incretins. Gastric inhibitory polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) are incretins. In...
20.
Fujita H, Morii T, Fujishima H, Sato T, Shimizu T, Hosoba M, et al.
Kidney Int
. 2013 Oct;
85(3):579-89.
PMID: 24152968
Glucagon-like peptide-1 (GLP-1) is a gut incretin hormone that has an antioxidative protective effect on various tissues. Here, we determined whether GLP-1 has a role in the pathogenesis of diabetic...